Find-A-Study

A randomized, double-blind, placebo controlled, 3-arm multicenter phase 3 study to assess the efficacy and safety of ianalumab in patients with active Sjögren's syndrome (NEPTUNUS-2)

Purpose

Category

IRB Number: 20220357HU
NCT Number: -
Open to Enrollment: Yes
Sponsor: -

Study Contact

Principal Investigator
Agustin Escalante

Agustin Escalante
(210) 567-4682
escalante@uthscsa.edu

Jose Restrepo Suarez
(210) 567-4656
restreposuar@uthscsa.edu

Eligibility

Eligible Ages
Eligible Genders
Accepts Healthy Volunteers: No

Inclusion Criteria

Exclusion Criteria

Study Design

Arm Groups